Lexicon Pharmaceuticals Inc $1.49

down -0.05


15/9/2014 04:00 PM  |  NASDAQ : LXRX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get LXRX Trend Analysis - it has underperformed the S&P 500 by 50%

Partner Headlines

  1. Lexicon Announces A Publication In The American Diabetes Association's ...

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. Gabelli Downgrades Lexicon Pharmaceuticals To Hold

    Benzinga
  4. FOMC To End QE In October; The Container Store Shares Slide

    Benzinga
  5. AeroVironment Surges On Upbeat Results; The Container Store Shares Slide

    Benzinga
  6. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. US Stock Futures Flat; All Eyes On Fed Minutes

    Benzinga
  9. Lexicon And JDRF Collaborate For Phase 2 Clinical Trial Of LX4211 In Type ...

    Benzinga
  10. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  11. Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat ...

    Benzinga
  12. Morning Market Movers

    Benzinga
  13. US Stock Futures Flat; Citigroup Earnings In Focus

    Benzinga
  14. Benzinga's Top Initiations

    Benzinga
  15. UPDATE: Bank of America Initiates Underperform On Lexicon Pharmaceuticals, ...

    Benzinga
  16. Benzinga's Top #PreMarket Losers

    Benzinga
  17. Lexicon Phase 2 Study Of LX1033 In IBS-d Shows Differences Between Placebo ...

    Benzinga
  18. Benzinga's Top Pre-Market Losers

    Benzinga
  19. Lexicon Pilot Study of Telotristat Etiprate In Ulcerative Colitis Achieves ...

    Benzinga
  20. Market Wrap For Tuesday, October 1: Government Down, Markets Up

    Benzinga
  21. Mid-Afternoon Market Update: Markets Remain Up As Government Shutdown Continues

    Benzinga
  22. Mid-Day Market Update: US Stocks Extend Gains; Lexicon Shares Surge

    Benzinga
  23. Mid-Morning Market Update: Markets Rise; Walgreen Earnings Surge 86%

    Benzinga
  24. Morning Market Movers

    Benzinga
  25. Benzinga's Top Pre-Market Gainers

    Benzinga
  26. Lexicon Pharma Reports Results from Trial of LX4211, Says Met Primary Goal, ...

    Benzinga
  27. Lexicon Pharmaceuticals Provides Clinical Pipeline Update

    Benzinga
  28. Stocks Surge as Fiscal Cliff Deal Appears Close

    Benzinga
  29. Mid-Day Market Update: Political Indecision Looms, Yet Markets Rise

    Benzinga
  30. Mid-Morning Market Update: Markets Rise Ahead of Fiscal Cliff, Cott Falls

    Benzinga
  31. Mid-Morning Market Update: Caribou Bought Out; Clearwire Plummets

    Benzinga
  32. Lexicon Pharma Shares Rise Following FDA Fast Track Designation for LX1 ...

    Benzinga
  33. Lexicon Genetics Inc. Reports Operating Results (10-Q)

    GuruFocus
  34. Lexicon Pharma Says Primary Efficacy Endpoint Was Achieved

    Benzinga
  35. Lexicon Prices 17.5M Shares At $2.25 per Share

    Benzinga
  36. Lexicon Announces Proposed Common Stock Offering

    Benzinga
  37. Benzinga's Top Pre-Market Gainers

    Benzinga
  38. Benzinga's Top Pre-Market Gainers

    Benzinga
  39. A Peek Into The Market Before The Trading Starts

    Benzinga
  40. A Peek Into The Market Before The Trading Starts

    Benzinga
  41. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies

    Benzinga
  42. Lexicon Genetics Inc. Reports Operating Results (10-Q)

    GuruFocus
  43. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second ...

    Benzinga
  44. A Peek Into The Market Before The Trading Starts

    Benzinga
  45. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients ...

    Benzinga
  46. SBA Communications Corporation, The Ryland Group Among Stocks Hitting 52-Week ...

    FoxBusiness
  47. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on ...

    FoxBusiness
  48. Benzinga's Top Pre-Market Gainers

    Benzinga
  49. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 ...

    Benzinga
  50. LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 Diabetes

    Benzinga
Trading Center